Serrano-Combarro et al. Abatacept in RA-ILD. 343 patients. In 23.3% ILD progressed on abatacept. Is that good or bad? We

Social Author Image

https://pbs.twimg.com/profile_images/1389468430160510976/sooz0Ud3_normal.jpg

Tweet Author

Social Author Name

Richard Conway

Tweet Content

Serrano-Combarro et al. Abatacept in RA-ILD. 343 patients. In 23.3% ILD progressed on abatacept. Is that good or bad? We need comparative studies! @RheumNow #ACR24 Abstr#0475 https://t.co/nUEDdjGguA https://t.co/sXEF72MafK

Links

Rheumatoid Arthritis - Progressive Interstitial Lung Disease with Abatacept: Da… https://acrabstracts.org/abstract/rheumatoid-arthritis-progressive-interstitial…

https://x.com/RichardPAConway/status/1857821934110572580/photo/1

Show on Archive Page

On

Display in Search Results

On

PDQ

Off

Topics

Serrano-Combarro et al. Abatacept in RA-ILD. 343 patients. In 23.3% ILD progressed on abatacept. Is that good or bad? We

Do you get our email newsletter?